John White, a biotechnology engineer, was no stranger to data or innovation. But when diagnosed with prostate cancer, he faced a reality that numbers can’t always predict. Standard treatments failed. So he turned to a clinical trial—where immunotherapy didn’t just extend his life. It gave it back.

📖 Read his journey—https://www.cancerresearch.org/stories/patients/john-white

At @Clinakos, we see stories like John’s not just as inspiring, but as instructive.

They underscore what we strive to solve:

🔍 Identifying the right patients for the right trials—faster

🧠 Integrating real-world and clinical data to drive earlier interventions

📈 Supporting evidence generation for life-saving innovations

John’s dual lens as a patient and scientist reminds us:

📌 The future of oncology depends on data that connects, informs, and empowers—in the real world.

💡 Let’s not just raise awareness. Let’s raise the standard of care.

👉Follow us at Clinakos Inc.